The Role of Metabolic Lipases in the Pathogenesis and Management of Liver DiseaseHEPATOLOGYIF15.82020-09-2831OAAI
Metabolic regulation of hepatic PNPLA3 expression and severity of liver fibrosis in patients with NASHLIVER INTERNATIONALIF5.22020-03-0122OAAI
Monoacylglycerol Lipase Inhibition Protects From Liver Injury in Mouse Models of Sclerosing CholangitisHEPATOLOGYIF15.82019-12-3022OAAI
PNPLA3 I148M Variant Impairs Liver X Receptor Signaling and Cholesterol Homeostasis in Human Hepatic Stellate CellsHEPATOLOGY COMMUNICATIONSIF4.62019-07-1530OAAI
Lack of monoacylglycerol lipase prevents hepatic steatosis by favoring lipid storage in adipose tissue and intestinal malabsorptionJOURNAL OF LIPID RESEARCHIF4.12019-07-0129OAAI
Monoacylglycerol lipase deletion protects against obesity-induced hepatic steatosis via PPARg regulation in adipose tissue and fatty acid malabsorption in the intestineJOURNAL OF HEPATOLOGYIF332019-04-010PREAI
Lack of monoacylglycerol lipase protects from MCD-induced hepatic inflammation and fibrosisJOURNAL OF HEPATOLOGYIF332019-04-010PREAI
Monoacylglycerol lipase inhibition protects from hepatic inflammation and fibrosis in mouse models of sclerosing cholangitisJOURNAL OF HEPATOLOGYIF332019-04-010PREAI
The I148M PNPLA3 impairs LXR signaling and cholesterol metabolism in human hepatic stellate cellsJOURNAL OF HEPATOLOGYIF332018-04-010PREAI
AQP3 is regulated by PPARγ and JNK in hepatic stellate cells carrying PNPLA3 I148MSCIENTIFIC REPORTSIF3.92017-11-0718OAAI
The PNPLA3 I148M Variant Modulates the Fibrogenic Phenotype of Human Hepatic Stellate CellsHEPATOLOGYIF15.82017-04-18191OAAI
The I148M PNPLA3 variant is a novel key player modulating the proinflammatory and profibrogenic phenotype of human hepatic stellate cellsJOURNAL OF HEPATOLOGYIF332017-01-010PREAI
Activated primary stellate cells show decreased aquaporin 3 expression in parallel with cellular senescence which is restored with PPAR-γ agonist establishing quiescenceJOURNAL OF HEPATOLOGYIF332017-01-010PREAI